Skip to Main Content

Paper Details

Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
4
2023
Author NameAffiliation
Katherine S PanageasMemorial Sloan Kettering Cancer Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2